- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01655498
A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE) (LIFE)
May 22, 2015 updated by: Pelvalon, Inc.
A Clinical Evaluation of the LivSure Vaginal Bowel Control (VBC) System for the Treatment of Fecal Incontinence in Women.
The objective of this study is to obtain preliminary efficacy and safety data on the use of the LivSure System (now called the "Eclipse™ System") in women with fecal incontinence.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35249
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- History of FI for at least 6 months
- Baseline diary requirement for min # of FI episodes in a two-week period
- Ability to manage investigational device insertion and removal
- Successful fitting of study device
- Willing and able to give written informed consent to participate in the study
Exclusion Criteria:
- Chronic rectal, anal or pelvic pain
- Any vaginal prolapse that extends beyond the plane of the hymen.
- Previous rectal or pelvic floor surgery within the last 12 months (24 months in the case of cancer)
- Congenital anorectal malformation
- Chronic watery diarrhea unmanageable by drugs or diet as primary cause of FI
- Inflammatory bowel disease
- Presence of a vaginal, anal, rectal or urethral fistula or anastomosis
- Presence of a vaginal, rectal or bladder tumor
- Presence of an open wound or tear in the vagina or anus by exam
- Presence or history of rectovaginal fistula
- Atrophic vaginal tissue as determined by symptoms or visualization
- Current vaginal or urinary infection requiring treatment
- History of recurrent urinary or vaginal infections
- Subject is currently pregnant or planning pregnancy in next 5 months
- Concurrent use of any intra-vaginal device that would interfere with LivSure (now called Eclipse) placement or wearing
- Any significant medical condition (e.g., significant psychiatric or neurological disorders, active alcohol/drug abuse, etc.) or other factor that the investigator believes would interfere with study participation and/or increase subject risk
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Vaginal Bowel Control
A vaginal bowel control system intended to manage fecal incontinence.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of FI Episodes
Time Frame: 1 Month
|
Subjects with at least a 50% reduction in FI episodes (major or minor soiling)
|
1 Month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Incontinent Days
Time Frame: 1 Month
|
Change in number of incontinent days while wearing the device during the 2-week assessment period as compared to the baseline 2-week assessment period
|
1 Month
|
Device-related Adverse Events
Time Frame: 1month
|
The number of overall adverse events rated as probably or definitely related to the study device.
|
1month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Matthews CA, Varma MG, Takase-Sanchez MM, Hale DS, Van Drie D, Muir T, Wells E, Jannelli M, Richter HE. Characteristics Associated With Successful Fitting of a Vaginal Bowel Control System for Fecal Incontinence. Female Pelvic Med Reconstr Surg. 2016 Sep-Oct;22(5):359-63. doi: 10.1097/SPV.0000000000000290.
- Richter HE, Matthews CA, Muir T, Takase-Sanchez MM, Hale DS, Van Drie D, Varma MG. A vaginal bowel-control system for the treatment of fecal incontinence. Obstet Gynecol. 2015 Mar;125(3):540-547. doi: 10.1097/AOG.0000000000000639.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (ACTUAL)
January 1, 2014
Study Completion (ACTUAL)
March 1, 2014
Study Registration Dates
First Submitted
July 24, 2012
First Submitted That Met QC Criteria
August 1, 2012
First Posted (ESTIMATE)
August 2, 2012
Study Record Updates
Last Update Posted (ESTIMATE)
May 27, 2015
Last Update Submitted That Met QC Criteria
May 22, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CA003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fecal Incontinence
-
Batterjee Medical CollegeBenha UniversityCompleted
-
Badr UniversityCompletedFecal Incontinence in ChildrenEgypt
-
Hospital Mutua de TerrassaCompletedGas Incontinence | Soilings, Fecal
-
RDD Pharma LtdWithdrawnIdiopathic Fecal IncontinenceIsrael
-
Nantes University HospitalCompletedConstipation Aggravated | Fecal Incontinence With Fecal UrgencyFrance
-
Queen Mary University of LondonCompletedBowel Incontinence | Faecal Incontinence
-
The Functional Gut ClinicRecruiting
-
Region SkaneTerminatedFecal Incontinence | Anal IncontinenceSweden
-
San Diego State UniversityUniversity of California, San DiegoCompleted
Clinical Trials on vaginal bowel control system (LivSure)
-
Pelvalon, Inc.CompletedFecal IncontinenceUnited States
-
US Department of Veterans AffairsCompleted
-
Bo-In LeeSt Vincent's Hospital; Incheon St.Mary's Hospital; Daejeon St. Mary's hospitalUnknownIrritable Bowel Syndrome | Inflammatory Bowel DiseasesKorea, Republic of
-
University of ManitobaManitoba Spinal Cord Injury Research Committee; Canadian Paraplegic AssociationCompleted
-
Assiut UniversityCompleted
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedVaginal Infection | Labor Induction | Effect Increased | Dinoprostone Vaginal InsertTurkey
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingShort Cervical LengthUnited States
-
Karolinska InstitutetCompleted
-
University of California, San FranciscoOrganonCompleted
-
CONRADCompleted